TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/14/20 18:01 | 5/13/20 | TXG | 10X Genomics, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Foresite Capital Management I, LLC | CA | T | S.d | -116,189 | 80.13 | 0 | -1,450 | -35 | 2,677 | I | |||||||||||||||
3/19/20 17:15 | 3/17/20 | TXG | 10X Genomics, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Foresite Capital Management I, LLC | CA | T | S.d | -44,250 | 59.00 | 0 | -750 | -71 | 313 | I | |||||||||||||||
9/16/19 17:26 | 9/12/19 | TXG | 10X Genomics, Inc. | DE | Electr | LabEq | Laboratory Analytical Instrum | Foresite Capital Management I, LLC | CA | T | P.d | 7,313 | 39.00 | 0 | 188 | New | 188 | I | |||||||||||||||
10/16/13 12:26 | 5/17/13 | AMBI | Ambit Biosciences Corp | DE | Health | Drug | Pharmaceutical Preparations | Foresite Capital Management I, LLC | CA | T | P.m | 551 | 6.93 | 0 | 80 | 4 | 2,080 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |